Report Library
View More
Datamonitor Healthcare Infectious D...
February 11, 2026
Datamonitor Healthcare CV&Met: Syst...
February 11, 2026
Datamonitor Healthcare Oncology: NH...
February 11, 2026
Datamonitor Healthcare Oncology: Ga...
February 11, 2026
Autism Spectrum Disorder (ASD) KOL ...
February 10, 2026
Autism Spectrum Disorder (ASD) KOL ...
February 9, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Dealmaking Quarterly Statistics, Q4...
February 5, 2026
Financing Quarterly Statistics, Q4 ...
February 5, 2026
Datamonitor Healthcare I&I: Axial S...
February 4, 2026
Datamonitor Healthcare CV&Met: Cach...
February 4, 2026
Datamonitor Healthcare Urology: Ove...
February 4, 2026
Datamonitor Healthcare Oncology: Bi...
February 4, 2026
Datamonitor Healthcare Oncology: Th...
February 4, 2026
Gene, Cell, & RNA Therapy Landscape...
February 3, 2026
Sjögren’s Disease KOL Interview - U...
February 3, 2026
Sjögren’s Disease KOL Interview - U...
February 3, 2026
Dry AMD KOL Interview - France
February 1, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 2/13/26 | Novartis (NVS) | Vanrafia for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/11/26 | BioRestorative Therapies (BRTX) | BRTX-100 for Musculoskeletal Conditions | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/5/26 | Incyte (INCY) | Pemazyre for Brain Cancer (Malignant Glioma; AA and glioblastoma) | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/2/26 | Skye Bioscience (SKYE) | nimacimab for Obesity | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/1/26 | Pharming (PHAR) | Joenja for Activated PI3K Delta Syndrome (APDS) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |